Overcoming resistance to standard CD19-targeted CAR T using a novel triple antigen targeted vector
Translational Candidate A tri-specific chimeric antigen receptor (CAR) T cell product that will prevent relapse since targets 3 different tumor antigens Area of Impact Relapse associated with single or double…